sts101
Generic: dihydroergotamine mesylate
sts101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Satsuma Pharmaceuticals, Inc. (STSA) | Phase 3 |
Get deeper analysis on sts101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis